Australian Pharmaceutical Industries Ltd operates within the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Australian Pharmaceutical Industries Ltd with three other drug stores in Australasia: Ecofibre Ltd (2020 sales of 50.72 million Australian Dollars [US$36.80 million] of which 92% was Ananda Health), Sigma Healthcare Ltd (3.34 billion Australian Dollars [US$2.43 billion] of which 100% was Healthcare), and McPherson's Limited (222.55 million Australian Dollars [US$161.50 million] of which 93% was Australia).

Sales Analysis. During the second fiscal quarter of 2021, sales at Australian Pharmaceutical Industries Ltd totalled A$1.98 billion. This is a drop of 2.7% from the A$2.04 billion in sales at the company during the second quarter in 2020. During the year ended August of 2020, sales at Australian Pharmaceutical Industries Ltd were A$4.02 billion (US$2.92 billion). This is a very small increase of 0.2% versus 2019, when the company's sales were A$4.02 billion. Despite this increase, sales are still slightly below the level achieved in 2018, when Australian Pharmaceutical Industries Ltd reported sales of A$4.04 billion. Sales of Australia saw an increase of 0.3% in 2020, from A$3.96 billion to A$3.97 billion. Not all segments of Australian Pharmaceutical Industries Ltd experienced an increase in sales in 2020: sales of New Zealand fell 9.3% to A$47.81 million. (However, this segment's sales were only a very small portion of the company's overall sales).